Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.583,07
-0,10%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Becton Dickinson and Company (BDX) Becton Dickinson and Company (BDX) Notizie

Becton Dickinson and Company

BDX
226,95
0,51 (0,23%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202422:20EDGAR2Form 144 - Report of proposed sale of securities
19/12/202416:49EDGAR2Form ARS - Annual Report to Security Holders
19/12/202416:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/12/202416:36EDGAR2Form DEF 14A - Other definitive proxy statements
17/12/202412:50PRNUSBD and Babson Diagnostics Launch Innovative Fingertip Blood..
16/12/202422:32PRNUSBD Resolves Previously Disclosed SEC Investigation
11/12/202402:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202402:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202422:47EDGAR2Form 144 - Report of proposed sale of securities
06/12/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202422:31EDGAR2Form 144 - Report of proposed sale of securities
06/12/202422:31EDGAR2Form 144 - Report of proposed sale of securities
05/12/202422:42EDGAR2Form 144 - Report of proposed sale of securities
05/12/202422:05GLOBEMaravai LifeSciences Appoints R. Andrew Eckert as Chairman..
30/11/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202415:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202420:15PRNUSFirst of Its Kind HPV Self-Collection Study Launched to..
19/11/202422:15PRNUSBD to Present at the 7th Annual Evercore ISI HealthCONx..
07/11/202412:37EDGAR2Form 8-K - Current report
07/11/202412:30PRNUSBD Reports Fourth Quarter and Full Year Fiscal 2024..
07/11/202412:25PRNUSBD Board Increases Dividend for 53rd Consecutive Year
05/11/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202411:50PRNUSBD Launches Enhanced Intraosseous System, Enabling Vascular..
29/10/202411:50PRNCAWomen in Canada Can Now Collect Their Own Sample at Home for..
25/10/202412:53PRNUSBD Named Among the 100 Best Corporate Citizens of 2024
14/10/202412:45PRNUSBD Announces New Robotics Solution to Automate, Standardize..
10/10/202422:15PRNUSBD to Announce its Fiscal 2024 Fourth Quarter and Full Year..
02/10/202423:03EDGAR2Form 8-K - Current report
02/10/202423:00PRNUSBD Reaches Agreement to Resolve Vast Majority of Hernia..
26/9/202412:50PRNUSNew Data Reveals BD's Artificial Intelligence Software..
18/9/202412:50PRNUSBD Expands Capacity for Advanced Prefillable Syringes and..
16/9/202417:52EDGAR2Form 144 - Report of proposed sale of securities
09/9/202421:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202420:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202420:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:30PRNUSBD Completes Acquisition of Critical Care from Edwards..
30/8/202422:16EDGAR2Form 8-K - Current report
22/8/202419:00PRNUSBD Celebrates 75 years of U.S. Manufacturing Excellence in..
21/8/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 226,72 Min: 224,185 Max: 227,13
Chiusura: 226,44

La tua Cronologia

NYSE
BDX
Becton Dickinson
LSE
77WZ
Acorn P2. 24
ASX
KME
Kip Mcgrath Education Ce...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network